Cita APA

Van Cutsem, E., Yoshino, T., Lenz, H. J., Lonardi, S., Falcone, A., Limón, M. L., . . . Argiles, G. (2018). Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1).

Citación estilo Chicago

Van Cutsem, E., et al. Nintedanib for the Treatment of Patients With Refractory Metastatic Colorectal Cancer (LUME-Colon 1). 2018.

Cita MLA

Van Cutsem, E., et al. Nintedanib for the Treatment of Patients With Refractory Metastatic Colorectal Cancer (LUME-Colon 1). 2018.